Citation

McKinzie DL, Winneroski LL, Green SJ, Hembre EJ, Erickson JA, Willis BA, Monk SA, Aluise CD, Baker TK, Lopez JE, Hendle J, Beck JP, Brier RA, Boggs LN, Borders AR, Cocke PJ, Garcia-Losada P, Lowe SL, Mathes BM, May PC, Porter WJ, Stout SL, Timm DE, Watson BM, Yang Z, Mergott DJ.: Discovery and Early Clinical Development of LY3202626, a Low-Dose, CNS-Penetrant BACE Inhibitor. J Med Chem, Volume 64 (12), 2021

Authors

Aluise CD, Baker TK, Beck JP, Boggs LN, Borders AR, Brier RA, Cocke PJ, Erickson JA, Garcia-Losada P, Green SJ, Hembre EJ, Hendle J, Lopez JE, Lowe SL, Mathes BM, May PC, McKinzie DL, Mergott DJ., Monk SA, Porter WJ, Stout SL, Timm DE, Watson BM, Willis BA, Winneroski LL, Yang Z

Journal

J Med Chem

Year

2021

DOI

10.1021/acs.jmedchem.1c00489

PubMed

34081466

Machine-readable

REST APIRDF